Oranda Therapeutics Announces Series A Funding Round to support its mission: to improve the lives of patients living with rare disease

Contributed by: Business Wire

Logo

Tags

Other Health

Research

General Health

Professional Services

Pharmaceutical

Genetics

Science

Biotechnology

Stem Cells

Finance

Other Science

Health

Funding

More Like This

PR Newswire associated0

Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment

PR Newswire associated0

Orphalan becomes the first European company to enter in China's Wilson Disease market

PR Newswire associated0

Norgine strengthens rare disease portfolio with acquisition of Theravia

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases

PR Newswire associated0

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

PR Newswire associated0

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies

PR Newswire associated0

Daewoong Pharmaceutical's Bersiporocin Receives 'Orphan Drug Designation' in Europe to Treat Idiopathic Pulmonary Fibrosis